Join the SmallCapReview mailing list.

AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More. 
MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx.    More.

INO Presents Progression Free Survival In Prostrate Cancer Patients

Robot ETF Betting On Small Cap Stocks Leaves Pros In The Dust

Market Sell Off Nearly Over And Will Be Reversed

Small Caps And Renewed Strength For Cyclicals

Volume Leaders
52 Week Highs/Lows
Small-Cap Index
Check Futures Here
Level II Quotes
Stock Screener
Performance by Industry
After Hours Market
World Markets


Visit Our Resources Page

Past Articles Worth Reading











 Where Small Cap Stocks Thrive Since 1999                                           

Small Cap Gainers: XPER Up 42%, HX Up 38%, INNT Up 37%, UXIN Up 17% 

Where Transports Lead, Small Cap Stocks Must Follow

9 Small Caps With Big Dividends

Why Small Caps Should Be In Your Portfolio

Market Makers by Symbols

3 Small Cap Dividend Stocks To Watch In 2019

Old Stock Certificates

7 Small Caps For Big Returns

Meaning of 5th Letter in Nasdaq Ticker Symbols

110 Financial Calculators

For Small Cap Stocks, A Recovery Is Taking Place

Small Cap ETFs Look To Rally

Small Cap Leaders For A Rough October

Small Cap Stocks Raise Hope That Selling Is Over Small-caps are seeing relative strength.

Worried About The Stock Markets Decline? Junk Bonds Aren't

Stock Market Pullback Brings Out The Buyers

Aurinia Pharmaceuticals (AUPH)



"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...

Myriad Genetics (MYGN)


"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...

Follow Us On


Small Cap Health Care Up More Than 40%

3 Overlooked Small Caps

Small Cap Growth Funds Are Now Up 23% For The Year

Small Caps Are Rising, Biotechs Can't Be Far Behind

Small Cap 600, Tracking The Technicals

Small Cap Growth Extends Dominance In One Year Returns

The Strong Case For Small Caps In Today's Market

Why 3200 On The S&P 500 Means Big Gains For Small Caps

Aurinia (AUPH) Reports Second Quarter Results

How To Invest In Small Caps Today

Small Cap Zombies Go Nowhere But Up

How Trade War Fears Are Boosting Small Caps

Why Investors Are Shifting To Small Cap Stocks

3 Reasons For The Small Cap Boom

Small Caps Lead Performance Year To Date

Small Stocks Dominate The Battle For Highest Returns

17 Small Caps That Can Double

The State Of Small Caps

Small Cap Stocks And Retail Among Top Picks

Small Caps Rising Through Year End

Small Cap Stocks Still Rule, Can Market Keep Going Up?

Hustle And Russell, Small Caps Hit All Time High

Small Cap Stocks Continue To Set New Highs

Small Caps Punch Above Their Weight

Small Cap Returns Are Leading

4 Undervalued Small Caps

Why Small And Mid Caps Could Be The Answer To Trade Jitters

Why Small Cap Indexes Are An Economic Baromete

10 Winners And 10 Losers In The Small Cap Sector

Small Cap Markets Recover

Hottest Small Caps Of 2018

Russell 2000 Has Posted Gains For Six Straight Weeks

Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.

"A Primer In Small Cap Investing"® is a leading destination for small-cap picks and news. The Purpose of is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"




© 1999-2018 Any questions or comments regarding this site should be directed to